Our Mission is to provide state-of-the-art comprehensive, multidisciplinary care to
patients with multiple sclerosis, their families, and caregivers in a personalized setting.
110 Cedar Street, Suite 110
Wellesley, MA
781-591-8300
The Elliot Lewis Center for Multiple Sclerosis Care is one of the largest multiple sclerosis centers in the metro Boston area and in all of New England. The Center offers state-of-the-art medical care, including diagnosis, symptom management, access to all approved disease modifying treatments, social work, on-site infusion center and the latest clinical research trials.
COVID-19 Update
We are doing everything we can to ensure the safety of our staff and patients.
To reduce any possible risk of exposure we are not allowing guests in the infusion suite. However, vaccinated guests are welcome to come in for appointments with the doctor. Unvaccinated guests should wait in their cars and may join by phone if they like.
All infusion patients will need to show proof of either vaccination or a negative COVID test within 7 days of their infusion.
Recommendation for a booster vaccine:
The CDC and FDA have approved a third vaccine for immunocompromised patients who have already received the Pfizer or Moderna vaccines. There is no current recommendation for a third vaccine in patients who had the J&J vaccine.
Patients who were vaccinated while on one of the following medications now qualify for a booster vaccine:
Ocrevus (ocrelizumab)
Rituxan (rituximab)
Kesimpta (ofatumumab)
Gilenya (fingolimod)
Mayzent (Siponimod)
Zeposia (ozanimod)
Ponvory (ponesimod)
If you are being treated with Ocrevus or Rituxan, we recommend waiting 3 months or more after your last infusion before getting the booster. You should wait at least 3 weeks after the booster before having your next infusion. Please contact us with any questions.
We recommend having a test for the spike protein antibodies 3-4 weeks after your booster. Please contact the office to arrange for testing.
Patients who were vaccinated while taking any of the following medications do not qualify for a booster at this time:
Copaxone (glatiramer)
Avonex / Rebif (beta interferon)
Tecfidera, Vumerity, dimethyl fumarate
Aubagio (teriflunomide)
Mavenclad (cladribine)
Tysabri (natalizumab)
It is likely that in the future, booster shots will become available to the general public. When that is announced, we will recommend that all of our remaining MS patients take it.
We strongly recommend that all of our patients receive one of the available COVID vaccines. If you have not been vaccinated, we recommend doing so immediately.
Coronavirus (COVID-19) Guidelines at The Elliot Lewis Center:
The Elliot Lewis Center has the following procedures in place to keep patients and staff safe.
Masks are required for patients and staff
Patients may bring vaccinated guests to their appointments. Unvaccinated guests may join by phone.
The infusion center remains open at reduced capacity to ensure safety.
All infusion patients will need to show proof of either vaccination or a negative COVID test within 7 days of their infusion.
All infusion chairs are a minimum of 6 feet apart
No visitors may accompany a patient into the infusion room
Masks are required at all times. Because of this, eating and drinking are not allowed in the infusion room apart from water. Please have a snack or meal prior to your arrival time.
Temperature is checked for all infusion patients
Telehealth/virtual visits remain an option for some follow up visits depending on the circumstances. Please contact the office if you prefer telehealth.
Presenting Research
The research team at The Elliot Lewis Center virtually presented posters at the annual Consortium for Multiple Sclerosis Centers and European Committee for Treatment and Research in Multiple Sclerosis Meetings.
Clinical Research
The Elliot Lewis Center has a robust research program, currently conducting clinical trials for relapsing and progressive forms of multiple sclerosis. Ongoing research includes phase II and phase III clinical trials, as well as phase IV observational trials, investigating the efficacy of new and existing multiple sclerosis therapies.
Educational Programs
ELC Education Day is an annual health fair and educational program. The event is free to patients, caregivers and supporters. Stay tuned for details on our next program
On Site Infusion Center
The Elliot Lewis Center has an on site independent infusion center for treatment with all approved multiple sclerosis infusion therapies. The infusion center is conveniently located within The Elliot Lewis Center, so access and care is streamlined.